AI assistant
Personalis, Inc. — Director's Dealing 2020
Dec 4, 2020
32721_dirs_2020-12-03_7a17cbf9-02dd-446c-9c73-cb43eae7c4d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Personalis, Inc. (PSNL)
CIK: 0001527753
Period of Report: 2020-12-01
Reporting Person: Chen Richard (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-01 | Common Stock | M | 40000 | $0.44 | Acquired | 152750 | Direct |
| 2020-12-01 | Common Stock | S | 14388 | $27.75 | Disposed | 138362 | Direct |
| 2020-12-01 | Common Stock | S | 25612 | $28.14 | Disposed | 112750 | Direct |
| 2020-12-02 | Common Stock | S | 293 | $27.76 | Disposed | 112457 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-01 | Stock Option (Right to Buy) | $0.44 | M | 40000 | Disposed | 2022-03-07 | Common Stock (40000) | Direct |
| 2020-12-01 | Stock Option (Right to Buy) | $28.17 | A | 30000 | Acquired | 2030-12-01 | Common Stock (30000) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The weighted average sale price for the transaction reported was $27.75, and the range of prices were between $27.02 and $28.01. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F3: The weighted average sale price for the transaction reported was $28.14, and the range of prices were between $28.025 and $28.43. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4: Shares sold to cover tax obligation from settlement of vested restricted stock units.
F5: The shares subject to the option are fully vested and exercisable.
F6: The shares subject to the option vest in 12 equal monthly installments starting on April 16, 2023.